Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Update From the Advisory Committee on Immunization Practices.Journal of the Pediatric Infectious Diseases Society2019
2019 Blood Viral Load in Symptomatic Congenital Cytomegalovirus InfectionJournal of Infectious Diseases.  219:1398-1406. 2019
2019 Neonatal herpes simplex virus infection among Medicaid-enrolled children: 2009–2015Pediatrics.  143. 2019
2019 Genotypic and phenotypic diversity of herpes simplex virus 2 within the infected neonatal populationmSphere.  4. 2019
2018 Update From the Advisory Committee on Immunization PracticesJournal of the Pediatric Infectious Diseases Society.  7:270-274. 2018
2018 The tail wagging the dog (or the challenges faced when the financing of medicine gets ahead of the science of medicine)Journal of Clinical Microbiology.  56. 2018
2018 Antiviral approaches for the treatment of herpes simplex virus infections in Newborn InfantsAnnual Review of Virology.  5:407-425. 2018
2018 Update From the Advisory Committee on Immunization PracticesJournal of the Pediatric Infectious Diseases Society.  7:181-187. 2018
2018 Closer to Universal Newborn Screening for Congenital Cytomegalovirus Infection but Far Away from Antiviral Therapy in All Infected InfantsJournal of Pediatrics.  199:7-9. 2018
2018 Antiviral treatment of childhood influenza: An updateCurrent Opinion in Pediatrics.  30:438-447. 2018
2018 Fulminant Haemophilus Influenzae Type a Infection in a 4-year-old with Previously Undiagnosed Asplenic HeterotaxyPediatric Infectious Disease Journal.  37:e108-e110. 2018
2018 Neonatal herpes simplex virus infectionsSeminars in Perinatology.  42:168-175. 2018
2018 Neonatal HSV disease: Balancing the low incidence with the need to treat promptlyPediatrics.  141. 2018
2018 Neonatal herpes simplex virus infectionNeoReviews.  19:e89-e96. 2018
2018 Clinical markers and outcomes of neonates with herpes simplex virus deoxyribonucleic acid persistence in cerebrospinal fluid in disseminated and central nervous system infectionJournal of the Pediatric Infectious Diseases Society.  7:E30-E33. 2018
2018 Update from the advisory committee on immunization practicesJournal of the Pediatric Infectious Diseases Society.  7:93-99. 2018
2017 Antiviral Drugs in Newborn and ChildrenPediatric Clinics of North America.  64:1403-1415. 2017
2017 Delayed recurrence of herpes simplex virus infection in the central nervous system after neonatal infection and completion of six months of suppressive therapyJournal of the Pediatric Infectious Diseases Society.  6:e177-e179. 2017
2017 Update from the advisory committee on immunization practicesJournal of the Pediatric Infectious Diseases Society.  6:311-316. 2017
2017 Intravenous zanamivir in hospitalized patients with influenzaPediatrics.  140. 2017
2017 Update: Interim guidance for the diagnosis, evaluation, and management of infants with possible congenital zika virus infection - United States, October 2017MMWR : Morbidity & Mortality Weekly Report.  66:1089-1099. 2017
2017 Assessing the febrile child for serious infection: A step closer to meaningful rapid resultsPediatrics.  140. 2017
2017 Elimination of perinatal hepatitis B: Providing the first vaccine dose within 24 hours of birthPediatrics.  140. 2017
2017 Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapyLancet Infectious Diseases.  17:e177-e188. 2017
2017 Preventing human papillomavirus–related cancers: we are all in this togetherAmerican Journal of Obstetrics and Gynecology.  216:576.e1-576.e5. 2017
2017 Update from the Advisory Committee on immunization practicesJournal of the Pediatric Infectious Diseases Society.  6:111-115. 2017
2017 Congenital Cytomegalovirus infection: Advances and challenges in diagnosis, prevention and treatmentThe Italian Journal of Pediatrics.  43. 2017
2017 Why neonatal herpes mattersThe Lancet Global Health.  5:e234-e235. 2017
2017 Screening for congenital cytomegalovirus after newborn hearing screening: What comes next?Pediatrics.  139. 2017
2017 Pathogenesis of Non-Zika Congenital Viral InfectionsJournal of Infectious Diseases.  216:S912-S918. 2017
2016 Countering vaccine hesitancyPediatrics.  138. 2016
2016 Medical versus nonmedical immunization exemptions for child care and school attendancePediatrics.  138. 2016
2016 Parental presence during treatment of ebola or other highly consequential infectionPediatrics.  138. 2016
2016 Recommendations for serogroup B meningococcal vaccine for persons 10 years and olderPediatrics.  138. 2016
2016 Vaccine delays, refusals, and patient dismissals: A survey of pediatriciansPediatrics.  138. 2016
2016 Update from the advisory committee on immunization practicesJournal of the Pediatric Infectious Diseases Society.  5:101-104. 2016
2016 Advances in the prevention and treatment of congenital cytomegalovirus infectionCurrent Opinion in Pediatrics.  28:81-85. 2016
2016 Update from the advisory committee on immunization practicesJournal of the Pediatric Infectious Diseases Society.  5:349-355. 2016
2015 Sequelae following postnatally acquired cytomegalovirus infection in very low-birth-weight neonates back to the futureJAMA Pediatrics.  169. 2015
2015 A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsisJournal of the Pediatric Infectious Diseases Society.  5:53-62. 2015
2015 Update from the advisory committee on immunization practicesJournal of the Pediatric Infectious Diseases Society.  5:3-6. 2015
2015 Acyclovir dosing and acute kidney injury: Deviations and directionJournal of Pediatrics.  166:1341-1344. 2015
2015 Valganciclovir for symptomatic congenital cytomegalovirus diseaseNew England Journal of Medicine.  372:933-943. 2015
2015 Neonatal Herpes Simplex Virus InfectionInfectious Disease Clinics of North America.  29:391-400. 2015
2015 Neonatal herpes simplex virus infection: Epidemiology and treatmentClinics in Perinatology.  42:47-59. 2015
2015 Quantitative herpes simplex virus concentrations in neonatal infectionJournal of Pediatrics.  166:793-795. 2015
2015 The authors replyNew England Journal of Medicine.  372:2463. 2015
2015 Update from the advisory committee on immunization practicesJournal of the Pediatric Infectious Diseases Society.  4:94-95. 2015
2015 Valganciclovir for Symptomatic Congenital Cytomegalovirus DiseaseObstetrical and Gynecological Survey.  70:489-490. 2015
2014 Preventing herpes simplex virus in the newbornClinics in Perinatology.  41:945-955. 2014
2014 Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infectionPediatrics.  134. 2014
2014 Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infectionPediatrics.  134:415-420. 2014
2014 Updated recommendations on the use of meningococcal vaccinesPediatrics.  134:400-403. 2014
2014 Recommended childhood and adolescent immunization schedule - United States, 2014Pediatrics.  133:357-363. 2014
2014 The scarlet HJournal of Infectious Diseases.  209:315-317. 2014
2014 Authors' response re: Clarifying costs and benefits of respiratory syncytial virus immunoprophylaxisPediatrics.  133. 2014
2014 Authors' responses in response to the letter from AmbrosePediatrics.  134:e1782-e1783. 2014
2014 Management of neonatal herpes simplex virus infection and exposureArchives of Disease in Childhood. Fetal and Neonatal Edition.  99. 2014
2014 Mother-to-child transmission of herpes simplex virusJournal of the Pediatric Infectious Diseases Society.  3. 2014
2014 Pediatric anthrax clinical managementPediatrics.  133. 2014
2014 The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approachClinical Pharmacology and Therapeutics.  96:380-389. 2014
2014 Update from the advisory committee on immunization practicesJournal of the Pediatric Infectious Diseases Society.  3:282-285. 2014
2014 Update from the advisory committee on immunization practicesJournal of the Pediatric Infectious Diseases Society.  3:94-97. 2014
2014 Update from the advisory committee on immunization practicesJournal of the Pediatric Infectious Diseases Society.  3:1-3. 2014
2013 Executive summary: Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: Recommendations from the national institutes of health, the centers for disease control and prevention, the HIV medicine association of the infectious diseases society of America, the pediatric infectious diseases society, and the American academy of pediatricsJournal of the Pediatric Infectious Diseases Society.  2:293-308. 2013
2013 Update from the advisory committee on immunization practicesJournal of the Pediatric Infectious Diseases Society.  2:309-311. 2013
2013 RSV immunoprophylaxis: Does the benefit justify the cost?Pediatrics.  132:915-918. 2013
2013 Recommendations for prevention and control of influenza in children, 2013-2014Pediatrics.  132. 2013
2013 A conversation with David w. Kimberlin, MD, FAAPPediatric Annals.  42:172. 2013
2013 Neonatal Herpes Simplex Virus InfectionsPediatric Clinics of North America.  60:351-365. 2013
2013 Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenzaJournal of Infectious Diseases.  207:709-720. 2013
2013 Guidance on management of asymptomatic neonates born to women with active genital herpes lesionsPediatrics.  131. 2013
2013 Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.Pediatrics.  131:383-386. 2013
2013 Maternal and neonatal herpes simplex virus infectionsAmerican Journal of Perinatology.  30:113-120. 2013
2013 Acyclovir dosing in the neonatal period and beyondJournal of the Pediatric Infectious Diseases Society.  2:179-182. 2013
2013 Update from the advisory committee on immunization practicesJournal of the Pediatric Infectious Diseases Society.  2:97-99. 2013
2012 Epidemiology and diagnosis of health care - Associated infections in the NICUPediatrics.  129. 2012
2012 Recommended childhood and adolescent immunization schedules - United States, 2012Pediatrics.  129:385-386. 2012
2012 The authors replyNew England Journal of Medicine.  366:90-91. 2012
2012 Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: A multicenter case seriesJournal of Pediatrics.  161. 2012
2012 Recommendations for prevention and control of influenza in children, 2012-2013Pediatrics.  130:780-792. 2012
2011 Meningococcal conjugate vaccines policy update: Booster dose recommendationsPediatrics.  128:1213-1218. 2011
2011 Oral acyclovir suppression and neurodevelopment after neonatal herpesNew England Journal of Medicine.  365:1284-1292. 2011
2011 PoliovirusPediatrics.  128:805-808. 2011
2011 Recommendations for administering hepatitis A vaccine to contacts of international adopteesPediatrics.  128:803-804. 2011
2011 The use of systemic and topical fluoroquinolonesPediatrics.  128. 2011
2011 Policy statement - Prevention of varicella: Update of recommendations for use of quadrivalent and monovalent varicella vaccines in childrenPediatrics.  128:630-632. 2011
2011 Policy statement - Recommendations for the prevention of perinatal group B streptococcal (GBS) diseasePediatrics.  128:611-616. 2011
2011 Policy statement - Rabies-prevention policy update: New reduced-dose schedulePediatrics.  127:785-787. 2011
2011 Control of varicella disease, version 2.0Journal of Infectious Diseases.  203:297-298. 2011
2011 Policy statement - Recommended childhood and adolescent immunization schedules - United States, 2011Pediatrics.  127:387-388. 2011
2010 Determination of appropriate dosing of influenza drugs in pediatric patientsClinical Pharmacology and Therapeutics.  88:704-707. 2010
2010 Policy statement - Recommendation for mandatory influenza immunization of all health care personnelPediatrics.  126:809-815. 2010
2010 Policy statement - Recommendations for prevention and control of influenza in children, 2010-2011Pediatrics.  126:816-826. 2010
2010 Oseltamivir dosing for influenza infection in premature neonatesJournal of Infectious Diseases.  202:563-566. 2010
2010 Clinical report - Head licePediatrics.  126:392-403. 2010
2010 Policy statement - Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: Use of 13-valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)Pediatrics.  126:186-190. 2010
2010 Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of ageClinical Infectious Diseases.  50:221-228. 2010
2010 Policy statement - Recommended childhood and adolescent immunization schedules - United States, 2010Pediatrics.  125:195-196. 2010
2010 Safety of oseltamivir compared with the adamantanes in children less than 12 months of agePediatric Infectious Disease Journal.  29:195-198. 2010
2010 Targeted antiviral prophylaxis with oseltamivir in a summer camp settingArchives of Pediatrics and Adolescent Medicine.  164:323-327. 2010
2009 Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous systemJournal of Clinical Virology.  46. 2009
2009 Policy statement - Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infectionsPediatrics.  124:1694-1701. 2009
2009 The role of immunoprophylaxis in the reduction of disease attributable to respiratory syncytial virusPediatrics.  124:1676-1679. 2009
2009 Policy statement - Recommendations for the prevention and treatment of influenza in children, 2009-2010Pediatrics.  124:1216-1226. 2009
2009 Antiviral therapy for herpesvirus central nervous system infections: Neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infectionAntiviral Research.  83:207-213. 2009
2009 Drinking water from private wells and risks to childrenPediatrics.  123:1599-1605. 2009
2009 Drinking water from private wells and risks to childrenPediatrics.  123. 2009
2009 Prevention of rotavirus disease: Updated guidelines for use of rotavirus vaccinePediatrics.  123:1412-1420. 2009
2009 Treatment of congenital cytomegalovirus infection: Implications for future therapeutic strategiesJournal of Antimicrobial Chemotherapy.  63:862-867. 2009
2009 Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review.Journal of Pediatric Pharmacology and Therapeutics.  14:86-93. 2009
2008 Exposure to nontraditional pets at home and to animals in public settings: Risks to childrenPediatrics.  122:876-886. 2008
2008 When Should You Initiate Acyclovir Therapy in a Neonate?Journal of Pediatrics.  153:155-156. 2008
2008 Prevention of influenza: Recommendations for influenza immunization of children, 2007-2008Pediatrics.  121. 2008
2008 Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus diseaseJournal of Infectious Diseases.  197:836-845. 2008
2008 Prevention of influenza: Recommendations for influenza immunization of children, 2008-2009Pediatrics.  122:1135-1141. 2008
2008 Recommended immunization schedules for children and adolescents - United States, 2008Pediatrics (Spanish Edition).  121:219-220. 2008
2007 Infection prevention and control in pediatric ambulatory settingsPediatrics (Spanish Edition).  120:650-665. 2007
2007 Prevention of human papillomavirus infection: Provisional recommendations for immunization of girls and women with quadrivalent human papillomavirus vaccinePediatrics (Spanish Edition).  120:666-668. 2007
2007 Prevention of varicella: Recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedulePediatrics (Spanish Edition).  120:221-231. 2007
2007 Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulationClinical Pharmacology and Therapeutics.  81:867-872. 2007
2007 Management of HSV encephalitis in adults and neonates: Diagnosis, prognosis and treatmentHerpes -Cambridge-.  14:11-16. 2007
2007 Antiviral therapy and prophylaxis for influenza in childrenPediatrics (Spanish Edition).  119:852-860. 2007
2007 Prevention of influenza: Recommendations for influenza immunization of children, 2006-2007Pediatrics (Spanish Edition).  119:846-851. 2007
2007 Varicella-zoster vaccine for the prevention of herpes zosterNew England Journal of Medicine.  356:1338-1343. 2007
2007 Herpes Simplex Virus Infections of the NewbornSeminars in Perinatology.  31:19-25. 2007
2007 Prevention of rotavirus disease: Guidelines for use of rotavirus vaccinePediatrics (Spanish Edition).  119:171-181. 2007
2007 Recommended immunization schedules for children and adolescents-United States, 2007Pediatrics (Spanish Edition).  119:207-208. 2007
2006 The use of systemic fluoroquinolonesPediatrics (Spanish Edition).  118:1287-1292. 2006
2006 Prevention of pertussis among adolescents: Recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccinePediatrics (Spanish Edition).  117:965-978. 2006
2006 Diagnosis of herpes simplex virus in the era of polymerase chain reactionPediatric Infectious Disease Journal.  25:841-842. 2006
2005 Diagnosis of herpes simplex virus infections of the CNSExpert Review of Molecular Diagnostics.  5:537-547. 2005
2005 Antiviral therapies in children: Has their time arrived?Pediatric Clinics of North America.  52:837-867. 2005
2005 Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous systemJournal of Infectious Diseases.  191:227-233. 2005
2005 Herpes simplex virus infections in neonates and early childhoodSeminars in Pediatric Infectious Diseases.  16:271-281. 2005
2005 Herpes simplex: Encephalitis children and adolescentsSeminars in Pediatric Infectious Diseases.  16:17-23. 2005
2005 Neonatal herpes: What have we learnedSeminars in Pediatric Infectious Diseases.  16:7-16. 2005
2005 Seminars in Pediatric Infectious Diseases: IntroductionSeminars in Pediatric Infectious Diseases.  16:4-5. 2005
2004 Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosisAntiviral Research.  63:141-151. 2004
2004 Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis) - Resistant mutantsJournal of Infectious Diseases.  190:975-978. 2004
2004 Neonatal HSV infections: The global pictureHerpes -Cambridge-.  11:31-32. 2004
2004 Genital HerpesNew England Journal of Medicine.  350:1970-1977+2017. 2004
2004 Clinical practice. Genital herpes.New England Journal of Medicine.  350:1970-1977. 2004
2004 Neonatal Herpes Simplex InfectionClinical Microbiology Reviews.  17:1-13. 2004
2003 Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: Results of a randomized, prospective, controlled trialPediatrics.  112:363-367. 2003
2003 Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial.Pediatrics.  112:363-367. 2003
2003 Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: A randomized, controlled trialJournal of Pediatrics.  143:16-25. 2003
2003 Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitisPediatric Infectious Disease Journal.  22:335-340. 2003
2003 Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis.Pediatric Infectious Disease Journal.  22:335-341. 2003
2003 Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patientsPediatric Infectious Disease Journal.  22:239-244. 2003
2003 Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patients.Pediatric Infectious Disease Journal.  22:239-244. 2003
2003 Herpes simplex virus infections of the central nervous systemSeminars in Pediatric Infectious Diseases.  14:83-89. 2003
2003 Molecular diagnosis of viral infections of the central nervous systemClinics in Laboratory Medicine.  23:843-865. 2003
2002 Herpes simplex virus infections in the neonatal periodInfections in Medicine.  19:462-474. 2002
2002 Pharmacotherapy of recurrent respiratory papillomatosisExpert Opinion on Pharmacotherapy.  3:1091-1099. 2002
2002 Meningitis in the Neonate.Current Treatment Options in Neurology.  4:239-248. 2002
2002 Antiretroviral pharmacokinetics in the paediatric population: A reviewClinical Pharmacokinetics.  41:1115-1133. 2002
2002 Antiviral therapy for cytomegalovirus infections in pediatric patientsSeminars in Pediatric Infectious Diseases.  13:22-30. 2002
2001 Natural history of neonatal herpes simplex virus infections in the acyclovir eraPediatrics.  108:223-229. 2001
2001 Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infectionsPediatrics.  108:230-238. 2001
2001 Natural history of neonatal herpes simplex virus infections in the acyclovir era.Pediatrics.  108:223-229. 2001
2001 Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.Pediatrics.  108:230-238. 2001
2001 Advances in the treatment of neonatal herpes simplex infectionsReviews in Medical Virology.  11:157-163. 2001
2001 Acyclovir derivatives and other new antiviral agentsSeminars in Pediatric Infectious Diseases.  12:224-234. 2001
2000 Juvenile onset recurrent respiratory papillomatosis: Possibilities for successful antiviral therapyAntiviral Research.  45:83-93. 2000
1999 Neuroinvasion of human herpesviruses 6 and 7Herpes -Cambridge-.  6:60-63. 1999
1999 Viral encephalitis.Pediatrics in Review.  20:192-198. 1999
1998 PCR: A new diagnostic tool that re-defines spectrum of HSV diseaseHerpes -Cambridge-.  5:42-45. 1998
1998 Herpes simplex virusesClinical Infectious Diseases.  26:541-555. 1998
1998 Human herpesvirus-6: Neurologic implications of a newly-described viral pathogenJournal of NeuroVirology.  4:474-485. 1998
1998 Human herpesviruses 6 and 7: Identification of newly recognized viral pathogens and their association with human diseasePediatric Infectious Disease Journal.  17:59-68. 1998
1998 Prevention and treatment of congenitally and perinatally acquired herpesvirus infectionsInternational Antiviral News.  6:78-82. 1998
1997 Rubella immunizationPediatric Annals.  26:366-371. 1997
1997 Treatment of viral infections during pregnancy and the neonatal periodClinics in Perinatology.  24:267-283. 1997
1997 Prophylaxis and treatment of herpesvirus infections in childrenSeminars in Pediatric Infectious Diseases.  8:196-204. 1997
1996 Antiviral resistance: Mechanisms, clinical significance, and future implicationsJournal of Antimicrobial Chemotherapy.  37:403-421. 1996
1996 Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: Results of a phase I/II trialPediatric Infectious Disease Journal.  15:247-254. 1996
1996 Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus diseaseJournal of Infectious Diseases.  174:1162-1167. 1996
1995 Protein synthesis-dependent induction of interleukin-1β by lipopolysaccharide is inhibited by dexamethasone via mRNA destabilization in human astroglial cellsJournal of Clinical Immunology.  15:199-204. 1995
1995 Antiviral resistance - an emerging problemAntiviral Research.  26:365-368. 1995
1995 Antiviral resistance in clinical practiceAntiviral Research.  26:423-438. 1995
1995 Assays for antiviral drug resistanceAntiviral Research.  26:403-413. 1995
1995 Models of antiviral resistanceAntiviral Research.  26:415-422. 1995
1995 Modulation of expression of genes involved in the inflammatory response by lipopolysaccharide and temperature in cultured human astroglial cellsImmunological communications.  24:775-785. 1995
1995 Molecular mechanisms of antiviral resistanceAntiviral Research.  26:369-401. 1995
1995 Research initiatives in studies of antiviral resistance and consensus points and recommendationsAntiviral Research.  26:439-452. 1995

Chapter

Year Title Altmetric
2018 Antiviral Agents.  1551-1567.e6. 2018
2018 Herpes Simplex Virus.  1056-1065.e3. 2018
2018 Introduction to Herpesviridae.  1055-1055.e1. 2018
2017 Neurologic sequelae of congenital and perinatal infections.  501-522. 2017
2017 Neonatal herpes simplex virus infection.  395-410. 2017
2016 Antiviral therapy.  210-225. 2016
2014 Vaccines for viral diseases with significant central nervous system manifestations 2014
2012 Neonatal herpes simplex virus and congenital cytomegalovirus infections.  203-217. 2012
2012 Antiviral Agents.  1502-1518.e10. 2012
2010 Herpes simplex viruses 1 and 2.  1275-1280. 2010
2007 Antiviral therapy of HSV-1 and-2.  1153-1174. 2007
2007 HSV-1 and 2: Pathogenesis and disease.  589-601. 2007
2007 Immunotherapy of HSV infections-Antibody delivery.  1332-1338. 2007
2005 Neonatal herpes simplex virus infection.  395-410. 2005

Principal Investigator On

  • Congenital and Perinatal Infections Rare Diseases Clinical Research Consortium (RDCRC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2024
  • Burden of Neonatal Herpes Simplex Virus Infections: Disease Incidence, Adequacy of Diagnostic Assessment, Disease Outcome, and Societal Costs  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2016 - 2024
  • (SCOUT CAP) A Phase IV Double-Blind, Placebo-Controlled, Randomized Trial to Evaluate Short Course vs. Standard Course Outpatient Therapy of Community Acquired Pneumonia in Children Vaccine and Treatment Evaluation Units  awarded by VANDERBILT UNIVERSITY MEDICAL CENTER 2014 - 2023
  • A Phase II, Single-Stage, Single Arm Investigation of Oral Valganciclovir Therapy in Infants with Asymptomatic Congenital Cytomegalovirus Infection  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2016 - 2021
  • Cross-sectional Cohort Study to Determine the Prevalence of Soil Transmitted Helminth (STH) Infections in School Age Children in a Rural Poor Community in Southern Alabama  awarded by CDC - Centers for Disease Control and Prevention/DHHS 2018 - 2020
  • Private Grant  awarded by ANTIVIRUS THERAPEUTICS, INC. 2014 - 2019
  • Monitoring Juvenile Onset Recurrent Respiratory Papillomatosis  awarded by EASTERN VIRGINIA MEDICAL SCHOOL 2017 - 2018
  • Retrospective Assessment of Juvenile Onset Recurrent Respiratory Papillomatosis  awarded by EASTERN VIRGINIA MEDICAL SCHOOL 2017 - 2018
  • Private Grant  awarded by ALIOS BIOPHARMA 2015 - 2018
  • Monitoring Juvenile Onset Recurrent Respiratory Papillomatosis  awarded by EASTERN VIRGINIA MEDICAL SCHOOL 2014 - 2016
  • Efficacy of Antiviral Suppression Therapy after Neonatal HSV Infection of CNS R34 Planning  awarded by Duke University 2015 - 2016
  • Private Grant  awarded by GlaxoSmithKline 2009 - 2015
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2008 - 2014
  • Private Grant  awarded by Gilead Sciences 2013 - 2014
  • Private Grant  awarded by CELLEX, INC. 2010 - 2013
  • Private Grant  awarded by CUBIST PHARMACEUTICALS 2009 - 2012
  • Teaching Activities

  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2019) 2019
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2019) 2019
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2019) 2019
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2019) 2019
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2019) 2019
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2019) 2019
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2019) 2019
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2019) 2019
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2018) 2018 - 2019
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2016) 2016
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2016) 2016
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2016) 2016
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2016) 2016
  • 52-401R - RESEARCH IN PEDIATRICS (Fall Term 2007) 2007 - 2008
  • Full Name

  • David Kimberlin